Monsanto, Bayer officials defend proposed $66 billion merger

September 20, 2016 by Mary Clare Jalonick
Bayer CropScience North America President and CSO Jim Blome, left, and Monsanto Company Executive Vice President & Chief Technology Officer Dr. Robb Fraley, are seen on Capitol Hill in Washington, Tuesday, Sept. 20, 2016, prior to testifying before the Senate Judiciary Committee hearing on a proposed $66 billion merger of American seed and weed-killer company Monsanto and German medicine and farm chemical maker Bayer. (AP Photo/Pablo Martinez Monsivais)

Top officials for Monsanto and Bayer defended their proposed $66 billion merger before skeptical senators on Tuesday, insisting that the deal would lead to greater investments in technology that could help American farmers.

Monsanto, the American seed and weed-killer, and Bayer, the German medicine and farm-chemical maker, responded to concerns from Iowa Sen. Charles Grassley, the Republican chairman of the Senate Judiciary Committee.

Grassley warned that consolidation and competition in the U.S. seed and agrochemical industry could hurt American farmers who are already dealing with an economic downturn.

"I'm afraid this consolidation wave has become a tsunami," Grassley said as the hearing opened.

After months of negotiations, St. Louis-based Monsanto Co. last week accepted an offer from Leverkusen, Germany-based Bayer AG that will pay $57 billion to Monsanto shareholders and assume $9 billion in Monsanto debt. The deal combines two of the six U.S. and European companies that dominate the agrochemical market, and would create a global agricultural and chemical giant with a broad array of products.

Robb Fraley, executive vice president and chief technology officer of Monsanto, and Jim Blome, president and CEO of Bayer CropScience North America, both testified that the combined investment is needed to meet a rising food demand.

Senate Judiciary Committee Chairman Sen. Charles Grassley, R-Iowa gives opening remarks on Capitol Hill in Washington, Tuesday, Sept. 20, 2016, before the start of the committee's hearing on a proposed $66 billion merger of American seed and weed-killer company Monsanto and German medicine and farm chemical maker Bayer. (AP Photo/Pablo Martinez Monsivais)
"This type of change enables more innovation and delivers better products to the farm even faster," Fraley said. "Farmers are best served when companies invest more in new technologies and accelerate the pace of their (research and development), which in turn spurs robust competition."

Blome noted that Monsanto has a greater presence in North America while Bayer's business is greater outside of North America.

"Monsanto is a perfect match to Bayer's agricultural business—combining complementary skills with limited geographic overlap," Blome said.

Grassley pointed to lower crop prices and higher seed prices, saying farmers are under "tremendous pressure" as the agriculture economy has slowed in the last couple of years.

The Iowa senator said antitrust regulators should closely watch consolidation of the agricultural biotech industry and coordinate oversight between agencies. He said the Federal Trade Commission is currently reviewing another merger between Syngenta AG and the China National Chemical Corp. and the Justice Department is looking at the merger of Dow Chemical and DuPont.

"The innovations of the companies in this room today have helped the world reach productivity levels which ease fears over meeting the long-term demands of our growing global population," Grassley said. "However, when does the size of companies and concentration in the market reach the tipping point, so much that a market becomes anti-competitive?"

Bayer CropScience North America President and CEO Jim Blome testifies on Capitol Hill in Washington, Tuesday, Sept. 20, 2016, before the Judiciary Committee hearing on a proposed $66 billion merger of American seed and weed-killer company Monsanto and German medicine and farm chemical maker Bayer. (AP Photo/Pablo Martinez Monsivais)

Executives from Syngenta, Dow AgroSciences and DuPont similarly defended their own merger plans at the hearing, saying that combined resources would help spur better innovations. Grassley said that the China National Chemical Corp. declined to testify.

Republican Sens. Thom Tillis of North Carolina and Orrin Hatch of Utah said the companies are facing too many government regulations and that is one reason for the mergers.

"No one this side of the dais should be surprised that they have to go through this to survive," Tillis said.

Democrats were less supportive. "You have to look at it from the consumer's point of view, and whether that is good policy," said Illinois Sen. Dick Durbin.

Farm groups testified that they are worried about the consequences.

Roger Johnson, head of the National Farmers Union, said that the mergers would mean that three companies would have more than 80 percent of U.S. corn seed sales and 70 percent of the global pesticide market.

This Aug. 31, 2015, file photo, shows the Monsanto logo on display at the Farm Progress Show in Decatur, Ill. The Senate is set to take a closer look at a proposed $66 billion merger of American seed and weed-killer company Monsanto and German medicine and farm chemical maker Bayer. (AP Photo/Seth Perlman, File)
"These mergers will result in fewer choices for farmers, higher prices, and less innovation," he said.

Bayer and Monsanto both own a variety of well-known products. Bayer sells crop protection chemicals used to kill weeds, insects and plant fungal diseases and also makes popular pharmaceutical products such as Bayer aspirin, Claritin allergy medicine and Alka Seltzer. Bayer also owns Dr. Scholl's foot products and Coppertone sunscreen.

Monsanto sells seeds for fruits, vegetables, corn, soybeans, cotton and other crops, plus heavily advertised Roundup weed killer. The company is a leading producer of genetically modified seeds engineered to resist drought and herbicides, among other things. Activists who oppose those so-called genetically modified organisms, or GMOs, have created a grassroots effort to vilify the company, even holding marches on city streets to protest Monsanto by name.

Bayer and Monsanto executives so far have not said if the Monsanto name will change. They say the combined company's seeds and North American business will still have a headquarters at Monsanto's St. Louis base.

Explore further: Senate panel to scrutinize proposed Bayer-Monsanto merger

Related Stories

Some farmers worry Monsanto merger will drive up costs

September 14, 2016

Bayer's buyout of St. Louis-based Monsanto has agricultural groups and farmers concerned that the merger will lead to higher prices for seed and crop protection products, though some experts are confident the deal will be ...

Bayer pushes bid for Monsanto closer to $56 billion

September 6, 2016

The German pharmaceutical giant Bayer AG sweetened its bid for Monsanto Tuesday, saying that its latest offer, now worth almost $56 billion reflects, "constructive negotiations" in its quest to build a global chemical and ...

Five things to know about the Bayer-Monsanto deal

September 14, 2016

German chemicals firm Bayer on Wednesday clinched a $66-billion deal to buy the US seeds and pesticides giant Monsanto, a high-profile takeover likely to face close scrutiny as debate rages in Europe over the use of genetically ...

Bayer takeover of Monsanto would create global giant

May 19, 2016

Bayer's potential acquisition of Monsanto would create a giant seed and farm chemical company with a strong footprint in the U.S., Europe and Asia, combining two businesses with complementary geographical focus.

Recommended for you

Catalyst advance removes pollutants at low temperatures

March 25, 2019

Researchers at Washington State University, University of New Mexico, Eindhoven University of Technology, and Pacific Northwest National Laboratory have developed a catalyst that can both withstand high temperatures and convert ...

EPA adviser is promoting harmful ideas, scientists say

March 22, 2019

The Trump administration's reliance on industry-funded environmental specialists is again coming under fire, this time by researchers who say that Louis Anthony "Tony" Cox Jr., who leads a key Environmental Protection Agency ...


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.